ALL
61
-2
MHK
50
2
PHM
43
2
ADT
48
2
PFE
38
2
AN
52
2
AAPL
55
2
MCD
46
4
FITB
72
2
MSI
47
-2
ADM
47
2
HRL
38
3
MTB
75
2
ETR
52
3
D
45
4
PG
43
2
MAS
63
3
HSY
50
5
AEE
58
3
CRM
59
-11
ALL
61
-2
MHK
50
2
PHM
43
2
ADT
48
2
PFE
38
2
AN
52
2
AAPL
55
2
MCD
46
4
FITB
72
2
MSI
47
-2
ADM
47
2
HRL
38
3
MTB
75
2
ETR
52
3
D
45
4
PG
43
2
MAS
63
3
HSY
50
5
AEE
58
3
CRM
59
-11
Financhill
Back

ClearShares Ultra-Short Maturity ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
62

OPER
ClearShares Ultra-Short Maturity ETF

Last Price:
$100.25
Seasonality Move:
-0.09%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
62
ClearShares Ultra-Short Maturity ETF (OPER) is a Buy

Is ClearShares Ultra-Short Maturity ETF a Buy, Sell or Hold?

  • The current ClearShares Ultra-Short Maturity ETF [OPER] share price is $100.28. The Score for OPER is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • OPER is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

OPER Stock Price Chart

What is ClearShares Ultra-Short Maturity ETF's stock price today?

  • The ClearShares Ultra-Short Maturity ETF share price today is $100.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OPER is experiencing selling pressure, which indicates risk of future bearish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

OPER Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 65.72 Buy
Chaikin Money Flow: -2615 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.06 - 100.26) Buy
Bollinger Bands (100): (100.1 - 100.34) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

OPER Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 100.21 Buy
20-day SMA: 100.13 Buy
50-day SMA: 100.18 Buy
200-day SMA: 100.25 Buy
8-day EMA: 100.22 Buy
20-day EMA: 100.17 Buy
50-day EMA: 98.55 Buy
200-day EMA: 64.43 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

ClearShares Ultra-Short Maturity ETF Earnings Growth & OPER Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

ClearShares Ultra-Short Maturity ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):